Phase 2 Absorption Clinical Trials
6 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–6 of 6 trials
Recruiting
Phase 2
Darbe Plus IV Iron to Decrease Transfusions While Maintaining Iron Sufficiency in Preterm Infants
Iron-Deficiency AnemiaIron-deficiencyPrematurity+1 more
University of Washington120 enrolled1 locationNCT05340465
Recruiting
Phase 2
Assess the Safety of ELGN-2112 in Preterm Infants Born Under 26 Weeks GA and IUGR Infants Born 26-32 Weeks GA
Intestinal Malabsorption
Elgan Pharma Ltd.60 enrolled1 locationNCT05904626
Recruiting
Phase 2
Evaluation of Obicetrapib on Antioxidant Levels in Plasma and HDL Particles of Healthy Volunteers
Antioxidant Absorption
NewAmsterdam Pharma100 enrolled1 locationNCT06982508
Recruiting
Phase 2
Safety and Efficacy of Crofelemer in Adult Patients With Short Bowel Syndrome and Intestinal Failure (SBS-IF) Without Colon-in-continuity (CIC)
Short Bowel SyndromeFunctional Gastrointestinal DisordersPost-Op Complication+2 more
Napo Therapeutics, S.p.A.18 enrolled8 locationsNCT06904872
Completed
Phase 2
The effect of resveratrol in red wine on cognitive function in older adults: Preliminary study
Absorption rates of resveratrolCognitive function in older adults
Swinburne University of Technology20 enrolled1 locationACTRN12611001288910
Not Yet Recruiting
Phase 2
Multiple-dose pharmacokinetics and ex vivo pharmacodynamics of the fixed-dosed artemisinin based combination therapies (ACTs) of the antimalarial drugs Artequick (artemisinin-piperaquine) and Coarsucam (artesunate-amodiaquine) in healthy male Vietnamese volunteers
Characterization of the pharmacokinetics (absorption, metabolism, distribution and elimination) of the components of the antimalarial drugs Artequick and Coarsucam in healthy Vietnamese volunteers will provide important data for dose optimization and measurement of interindividual variability in plasma drug concentrations.
Australian Department of Defence44 enrolled1 locationACTRN12609000846224